Airway management and perioperative adverse events in children with mucopolysaccharidoses and mucolipidoses: A retrospective cohort study. Issue 2 (27th January 2020)

• Record Type: Journal Article
• Authors: Dohrmann, Thorsten; Muschol, Nicole M.; Sehner, Susanne; Punke, Mark A.; Haas, Sebastian A.; Roeher, Katharina; Breyer, Sandra; Koehn, Anja F.; Ullrich, Kurt; Zöllner, Christian; Petzoldt, Martin
• Editors: Veyckemans, Francis
• Is Part Of: Paediatric anaesthesia. Volume 30:Issue 2(2020:Feb.)
• Page Start: 181
• Page End: 190
• Publication Date: 2020-01-27
• Subjects: anesthesia -- bronchoscopes -- intubation -- lysosomal storage diseases -- MPS -- supraglottic airway; Pediatric anesthesia -- Periodicals; 617.96798
• DOI: 10.1111/pan.13787
• Languages: English
• ISSNs: 1155-5645

Abstract

Abstract: Background: Children suffering from mucopolysaccharidoses (subtypes I, II, III, IV, VI, and VII) or mucolipidoses often require anesthesia, but are at high risk for perioperative adverse events. However, the impact of the disease subtype and the standard of care for airway management are still unclear. Aims: This study aimed to assess independent risk factors for perioperative adverse events in individuals with mucopolysaccharidoses/mucolipidoses and to analyze the interaction with the primary airway technique implemented. Methods: This retrospective study included individuals with mucopolysaccharidoses/mucolipidoses who underwent anesthesia at two high‐volume centers from 2002 to 2016. The data were analyzed in a multivariate hierarchical model, accounting for repeated anesthesia procedures within the same patient and for multiple events within a single anesthesia. Results: Of 141 identified inpatients, 67 (63 mucopolysaccharidoses and 4 mucolipidoses) underwent 269 anesthesia procedures (study cases) for 353 surgical or diagnostic interventions. At least one perioperative adverse event occurred in 25.6% of the cases. The risk for perioperative adverse events was higher in mucopolysaccharidoses type I (OR 8.0 [1.5‐42.7]; P = .014) or type II (OR 8.8 [1.3‐58.6]; P = .025) than in type III. Fiberoptic intubation through a supraglottic airway was associated with the lowest risk for perioperative adverse events and lowest conversion rate. Direct laryngoscopy was associated with a significantly higher risk for airway management problems than indirect techniques (estimated event rates 47.8% vs 10.1%, OR 24.05 [5.20‐111.24]; P < .001). The risk for respiratory adverse events was significantly higher for supraglottic airway (22.6%; OR 31.53 [2.79‐355.88]; P = .001) and direct laryngoscopy (14.8%; OR 14.70 [1.32‐163.44]; P = .029) than for fiberoptic intubation through a supraglottic airway (2.1%). Conclusions: The disease subtype and primary airway technique were the most important independent risk factors for perioperative adverse events. Our findings indicate that in MPS/ML children with predicted difficult airway indirect techniques should be favored for the first tracheal intubation attempt.